HOXA9 and colorectal adenocarcinoma: Furthermore, miR-633 in colorectal adenocarcinoma [87], miR-381-3p in human anaplastic thyroid carcinoma [88], microRNA-638 in breast cancer [55], miR-652 in Uveal Melanoma [46], miR-133b in colorectal cancer [89], and miR-139-5p in oral squamous carcinoma [90] were found to regulate the malignant behavior through targeting HOXA9.